Increased expression of focal adhesion kinase in thyroid cancer: Immunohistochemical study

Journal of Korean Medical Science

Volumn 19, Issue 5, 2004, Pages 710-715

  Kim, Sang Jin ^a   Park, Jin Woo ^a   Yoon, Ji Sung ^a   Mok, Ji O ^a   Kim, Yeo Joo ^a   Park, Hyeong Kyu ^a   Kim, Chul Hee ^a   Byun, Dong Won ^a   Lee, Yong Jin ^a   Jin, So Young ^a   Suh, Kyo Il ^a   Yoo, Myung Hi ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Focal Adhesion Kinase; Focal Adhesions; Immunohistochemistry; Protein Tyrosine Kinase; Thyroid Neoplasms; Thyroid Nodule

Indexed keywords

FOCAL ADHESION KINASE;

ADENOMA; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEDULLARY CARCINOMA; NODULAR GOITER; PAPILLARY CARCINOMA; PROTEIN EXPRESSION; STAINING; THYROID CANCER; THYROID CARCINOMA; TISSUE;

EID: 7544233460     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.5.710     Document Type: Article

References (42)

1. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules: final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 1968; 69: 537-40.
2. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
3. Zetter BR. Adhesion molecules in tumor metastasis. Semin Cancer Biol 1993; 4: 219-29.
4. Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999; 71: 435-78.
5. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 1992; 89: 5192-6.
6. Guan JL, Trevithick JE, Hynes RO. Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul 1991; 2: 951-64.
7. Kornberg LJ, Earp HS, Turner CE, Prockop C, Juliano RL. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins. Proc Natl Acad Sci USA 1991; 88: 8392-6.
8. Sinnett-Smith J, Zachary I, Valverde AM, Rozengurt E. Bombesin stimulation of p125 focal adhesion kinase tyrosine phosphorylation. J Biol Chem 1993; 268: 14261-8.
9. Zachary I, Rozengurt E. Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 1992; 71: 891-4.
10. Kornberg LJ. Focal adhesion kinase expression in oral cancers. Head Neck 1998; 20: 634-9.
11. Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of focal adhesion kinase gene and invasive cancer. Lancet 1993; 342: 1024-5.
12. FAK) in invasive human tumors. Cancer Res 1995; 55: 2752-5.
13. Glukhova M, Koteliansky V, Sastre X, Thiery JP. Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol 1995; 146: 706-16.
14. Owens LV, Xu L, Dent GA, Yang X, Sturge GC, Craven RJ, Cance WG. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 1996; 3: 100-5.
15. csk in human metastatic prostate carcinoma. Int J Cancer 1996; 68: 164-71.
16. Han NM, Fleming RY, Curley SA, Gallick GE. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: independence from c-src or c-yes activation. Ann Surg Oncol 1997; 4: 264-8.
17. Withers BE, Hanks SK, Fry DW. Correlations between the expression, phosphotyrosine content and enzymatic activity of focal adhesion kinase, pp125FAK, in tumor and nontransformed cells. Cancer Biochem Biophys 1996; 15: 127-39.
18. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, Simkins S, Xu L. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 2000; 6: 2417-23.
19. Moon HS, Park WI, Choi EA, Chung HW, Kim SC. The expression and tyrosine phosphorylation of E-cadherin/catenin adhesion complex, and focal adhesion kinase in invasive cervical carcinomas. Int J Gynecol Cancer 2003; 13: 640-6.
20. Zhao JH, Reiske H, Guan JL. Regulation of the cell cycle by focal adhesion kinase. J Cell Biol 1998; 143: 1997-2008.
21. Hungerford JE, Compton MT, Matter ML, Hoffstrom BG, Otey CA. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol 1996; 135: 1383-90.
22. Xu LH, Owens LV, Sturge GC, Yang X, Lui ET, Craven RJ, Cance WG. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ 1996; 7: 413-8.
23. Ilic D, Almeida EA, Schlaepfer DD, Dazin P, Aizawa S, Damsky CH. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 1998; 143: 547-60.
24. Frisch S, Vuori K, Ruoslahti E, Chan-Hui PY. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996; 134: 793-9.
25. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995; 377: 539-44.
26. Owen JD, Ruest PJ, Fry DW, Hanks SK. Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Mol Cell Biol 1999; 19: 4806-18.
27. Richardson A, Parsons JT. A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature 1996; 380: 538-40.
28. Sieg DJ, Hauck CR, Schlaepfer DD. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 1999; 112: 2677-91.
29. Cary LA, Chang JF, Guan JL. Stimulation of cell migration by overepression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 1996; 109: 1787-94.
30. Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA. CAS/Crk coupling serves as a molecular switch for induction of cell migration. J Cell Biol 1998; 140: 961-72.
31. Xu LH, Yang X, Bradham CA, Brenner DA, Baldwin AS Jr, Craven RJ, Cance WG. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways. J Biol Chem 2000; 275: 30597-604.
32. Xu LH, Yang X, Craven RJ, Cance WG. The COOH-teminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth Differ 1998; 9: 999-1005.
33. Almeida EA, Ilic D, Han Q, Hauck CR, Jin F, Kawakatsu H, Shlaepfer DD, Damsky CM. Matrix survival signaling from fibronectin via focal adhesion kinase to c-jun nh (2)-terminal kinase. J Cell Biol 2000; 149: 741-54.
34. Judson PL, He X, Cance WG, Le LV. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 1999; 86: 1551-6.
35. Rovin JD, Frierson HF Jr, Ledinh W, Parsons JT, Adams RB. Expression of focal adhesion kinase in normal and pathologic human prostate tissues. Prostate 2002; 53: 124-32.
36. Agochiya M, Brunton VG, Owens DW, Parkinson EK, Paraskeva C, Keith WN, Frame MC. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 1999; 18: 5646-53.
37. Kahana O, Micksche M, Witz IP, Yron I. The focal adhesion kinase (p125FAK) is constitutively active in human malignant melanoma. Oncogene 2002; 21: 3969-77.
38. Kim LT, Fleming JB, Lopez-Guzman C, Nwariaku F. Focal adhesions and associated proteins in medullary thyroid carcinoma cells. J Surg Res 2003; 111: 177-84.
39. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amster HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjold M, Komminoth P, Heudy GN, Mulligan LM. The relationship between specific RET proto-oncogene mutation and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. J Am Assoc 1996; 276: 1575-9.
40. Eng C, Mulligan LM. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease. Hum Mutat 1997; 9: 97-109.
41. Murakami H, Iwashita T, Asai N, Iwata Y, Narumiya S, Takahashi M. Rho-dependent and -independent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130 Cas mediated by Ret kinase. Oncogene 1999; 18: 1975-82.
42. Gimm O. Thyroid cancer. Cancer Lett 2001; 163: 143-56.